click below
click below
Normal Size Small Size show me how
Stack #131712
a MCPHS- Provider I- Ch 39- Assessment & Management of Pts w/Hepatic Disorders
Question | Answer |
---|---|
75% of liver's blood supply comes from | Portal vein |
Supplies liver with oxygen | Hepatic artery |
Most common phagocyte in human body | Kupffer cells |
Main function r/t Kupffer cells | Engulf particulate matter |
End product r/t gluconeogenesis | Ammonia |
Liver converts ammonia to | Urea |
Examples r/t Protein metabolism of liver | Synthesizes almost all plasma proteins including albumin, alpha & beta globulins, blood clotting factors |
Required for synthesis of prothrombin | Vitamin K |
Vitmains stored in large amounts in liver | A, B-complex and D |
Fraction of an administered medication that actually reaches systemic circulation | Bioavailability |
Bioavailability is decreased if medication is metabolized to a great extent by liver before it reaches systemic circulation | First-pass effect |
Enteropathic circulation | Pathway from hepatocytes to bile to intestines and back to hepatocytes |
Amount of bile salts excreted in feces | Small fraction |
Route r/t bilirubin elimination | Excreted to bile |
Most common changes to liver r/t Aging | Decreases in size, weight and total hepatic blood flow |
Abnormal liver function tests r/t Aging process | Abnormal results indicate abnormal liver function and are not result of aging |
Alcohol consumption r/t High risk for cirrhosis | Men:60-80 g/day or 4 cocktails, Women: 40-60 g/day |
Viral hepatitis vs. Alcoholic hepatitis r/t Liver tenderness | VH:tender, AH:nontender |
Amount of liver damage before liver function tests may become abnormal | 70%+ |
ALT level increase vs. AST level increase vs. GGT level increase r/t Liver function | ALT:primarily d/t liver disorders, AST:damage/death to organ tissues, GGT:cholestasis or alcoholic liver disease |
Acute vs. Chronic r/t More common liver dysfunction | Chronic |
Most common and significant symptoms r/t liver disease | Jaundice, Portal hypertension, Ascites, Varices, Nutritional deficiencies, Hepatic encephalopathy |
Hemolytic vs. Hepatocellular vs. Obstructive jaundice | Hemo:increased destruction of RBC's, Hepato:inability of damaged liver cells to clear normal amounts of bilirubin, O:extrahepatic obstruction from occulsion of bile duct |
Extrahepatic vs. Intrahepatic obstruction | I:obstruction involves small bile ducts w/in liver, E:occlusion of bile duct |
Urine & Stool r/t Obstructive jaundice | U:deep orange and foamy, S:light/clay-colored |
Pathophysiology r/t Varices | Develop d/t elevated pressure in veins |
Treatment goal r/t Pt w/ascites | Negative Na balance to reduce fluid retention |
Commercial salt substitutes r/t Physician approval | May contain ammonia which could cause hepatic coma, May also contain K |
Second treatment option r/t Ascites | Diuretic therapy |
Pathophysiology r/t Esophageal varices | Almost always d/t portal hypertension |
Factors contributing to hemorrhage r/t Esophageal varices | Muscular exertion, Straining at stool, Sneezing, Coughing, Vomiting, Esophagitis, Irritation of vessels d/t poorly chewed food, Reflux of stomach contents |
Signs r/t Potential hypovolemia | Cold clammy skin, Tachycardia, Drop in BP, Decreased urine output, Weak peripheral pulses |
Order to removing Balloon tamponade | Esophageal balloon deflated first, Pt monitored for recurrent bleeding, Gastric balloon deflated, Monitor for recurrent bleeding, Remove balloon tamponade |
Treatment of choice r/t Esophageal varices | Esophageal band ligation |
Surgical decompression prevents variceal bleeding | Decompression of portal circulation |
Precipating factors r/t Hepatic encephalopathy | Profound liver failure, Accumulation of ammonia and other toxic metabolites |
Earliest symptoms r/t Hepatic encephalopathy | Minor mental changes & motor disturbances |
Medication used to decrease serum ammonia levels | Lactulose |
Pathophysiology r/t Generalized edema | Hypoalbuminemia d/t decreased hepatic production of albumin |
Bleeding r/t Hepatic impairment | Production of clotting factors is reduced, Increased bruising and bleeding from wounds |
Hep A vs. Hep B r/t Transmission route | A:fecal-oral, B:blood |
Active vs. Passive immunity | Active acquire immunity:develop by own body, Passive acquired immunity:obtained from source outside of body like immune globulin, antiserum, or mother to baby |
Most frequent side effect r/t Hep C treatment | Hemolytic anemia |
Only risk factor r/t Hep D | Those w/Hep B |
Almost always present w/Hep E | Jaundice |
Common chemicals r/t Nonviral hepatitis | Carbon tet, Phosphorus, Chloroform & gold compounds |
Common med that leads to hepatitis | Acetaminophen |
Most common cause of acute liver failure | Drug-induced liver disease |
Sudden/severe impaired liver function in previously healthy Pt | Fulminant hepatic failure |
Common causes r/t Fulminant hepatic failure | Viral hepatitis, Toxic meds, Toxic chemicals, Metabolic disturbances, Structural changes |
Replacement of normal tissue w/diffuse fibrosis that disrupts liver function | Cirrhosis |
Alcoholic vs. Postnecrotic vs. Biliary cirrhosis | A:scar tissue surrounds portal areas, P:result of acute viral hepatitis, B:scar tissue around bile ducts |